Trump signs order to speed review of psychedelics, including the controversial drug ibogaine - AP News

Trump signs order to speed review of psychedelics, including the controversial drug ibogaine AP News

18 Apr, 16:02 — 18 Apr, 17:37

Why this matters

This executive order signals a potential shift in federal policy regarding psychedelic substances, which have shown promise in treating various mental health conditions but face significant regulatory hurdles. Accelerating their review could lead to new treatment options for veterans and others, while also raising questions about the safety and efficacy of these controversial drugs.

Key entitiesDonald Trump FDA Ibogaine

The Story

What 4 sources agree on, dispute, and miss

What sources agree on

Former President Trump signed an executive order regarding psychedelic drug treatments
The order aims to speed up the review process for these treatments
Ibogaine, a controversial psychedelic, is specifically mentioned in the context of the order

Key claims3 agreed · 1 unverified

✓

Trump signed an order to speed review of psychedelics, including ibogaine.

agreed·APReutersCNNbloomberg

✓

The order aims to accelerate access to psychedelic drug treatments.

agreed·ReutersCNN

✓

The order seeks to ease FDA restrictions on psychedelics.

agreed·bloomberg

Trump asked, 'Can I have some?' regarding psychedelic treatments.

unverified·CNN

Coverage gaps

Trump's comment, "Can I have some?"

ReportedCNN

MissingAPReutersbloomberg

The Story

Analyzing sources…

Source Diversity

Moderate (47/100)

4 sources30/33

Spectrum spread— 2/5 buckets covered8/33

Far L1

Far Left (1)

CNN

Left

Center3

Center (3)

APReutersbloomberg

Right

Far R

Geographic diversity— 2 regions9/34

US3Intl1

Political spectrum

LeftCenterRight

cnn

reuters

bloomberg

Outlet rating This story

SourceOutletiGeneral editorial lean of the outletStoryiHow they covered this specific storyToneFactuality

CNNcenter-leftcenter-leftanalyticalMostly Factualincludes lighthearted Trump anecdote

APcentercenterneutralVery Highfactual reporting on executive order

ReuterscentercenterneutralVery Highstraightforward reporting on policy action

bloombergcentercenterneutralHighfocus on FDA restrictions and policy

Coverage leans: balanced

The coverage is largely neutral and factual, focusing on the executive order's purpose. CNN includes a personal anecdote from Trump, adding a slightly more informal tone.

Sources

Showing 3 of 4 sources

APVery High1d ago